Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - DiamiR Biosciences Corp. [Member] - USD ($) |
May 31, 2025 |
May 31, 2024 |
|---|---|---|
| Schedule of Deferred Tax Assets and Liabilities [Line Items] | ||
| Tax benefit of net operating loss carry-forward (NOL) | $ 351,453 | $ 247,637 |
| FIN48 reduction in NOL | (269,420) | (219,793) |
| Stock compensation | 351,136 | 346,030 |
| Research and development expenses | 422,170 | 372,544 |
| Other | 1,152 | 2,432 |
| Total deferred tax assets: | 856,490 | 748,850 |
| Deferred tax liabilities | (8,152) | (4,583) |
| Net deferred tax assets: | 848,338 | 744,267 |
| Valuation allowance for deferred tax assets | (848,338) | (744,267) |
| Deferred tax assets, net of valuation allowance |
| X | ||||||||||
- Definition Deferred tax assets reduction in net operating loss carryforwards. No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets research and development expenses. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|